Incorporation of high-dose (131)I-metaiodobenzylguanidine treatment into tandem high-dose chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma: results of the SMC NB-2009 study

BACKGROUND: In our previous SMC NB-2004 study of patients with high-risk neuroblastomas, which incorporated total-body irradiation (TBI) with second high-dose chemotherapy and autologous stem cell transplantation (HDCT/auto-SCT), the survival rate was encouraging; however, short- and long-term toxic...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ji Won, Lee, Sanghoon, Cho, Hee Won, Ma, Youngeun, Yoo, Keon Hee, Sung, Ki Woong, Koo, Hong Hoe, Cho, Eun Joo, Lee, Suk-Koo, Lim, Do Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432997/
https://www.ncbi.nlm.nih.gov/pubmed/28511709
http://dx.doi.org/10.1186/s13045-017-0477-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432997/
https://www.ncbi.nlm.nih.gov/pubmed/28511709
http://dx.doi.org/10.1186/s13045-017-0477-0

Ejemplares similares